
    
      Prospective, international, multi-center, single-arm study with up to 60 months follow up to
      evaluate safety and effectiveness of BIOTRONIK's Dynetic-35 stent associated with the use of
      Passeo-35 Xeo for the treatment of peripheral artery disease (PAD) in subjects with
      atherosclerotic disease in iliac arteries
    
  